The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Louisa Ziglar, MD, FACR: ‘Everyone Can Be an Advocate’

Louisa Ziglar, MD, FACR: ‘Everyone Can Be an Advocate’

March 18, 2021 • By Leslie Mertz, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

When it comes to advocating for rheumatology, it’s never too early or late in your career to begin, and no effort is too small to have an impact. That’s the message from Louisa Ziglar, MD, FACR, a clinical rheumatologist with Arthritis & Rheumatism Associates near Washington, D.C. She has been a practicing physician for 15 years and recently joined the ACR’s Government Affairs Committee (GAC). She shared with The Rheumatologist her path to becoming an active advocate and how other ACR/ARP members can likewise step up and make a difference.

You Might Also Like
  • Advocate from Your Office the Week of March 14
  • Everybody Is Doing It: Are You an Advocate?
  • Why I Advocate for Rheumatology: Teaching the Basics
Also By This Author
  • Channel Policy Frustrations into Advocacy to Improve Patient Care
Louisa Ziglar headshot

Dr. Louisa Ziglar

TR: Why and how did you begin speaking out about rheumatology?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Ziglar: I started advocacy strictly out of frustration. Medicine has changed a lot over the last 15 years—there are things like step therapy, where I am told by managed care that patients have to first fail other treatments before what I prescribe can be given. This can extend the pain and damage my patients suffer from the disease. Then, the administrative burdens to try to appeal the medication denial—that pushed an inner desire for me to do something about it, and to let my congressmen and congresswomen know about some actions they can take to make things easier for patients. So I mainly just wrote letters to Congress to share my experiences as a practitioner and my patients’ experiences, so our representatives would know what’s going on.

TR: How did that transform into taking a bigger role in advocacy?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Ziglar: In 2019, I was speaking with Angus Worthing, MD, FACR, FACP, about how I would like to do more for the patients, and he introduced me to the GAC. That’s when I joined and learned about all the great behind-the-scenes work that the government affairs staff and GAC members do to get our voices heard. Since then, I’ve spent a lot of time learning about the issues, helping to get key messages across to legislators and meeting regularly with the GAC to see what other things we can do.

TR: Has the pandemic brought other issues to the forefront?

Dr. Ziglar: Before COVID, very few practices were doing telemedicine, and then within a matter of weeks, we were starting to see most of our patients that way. It was not only a struggle to implement, but also a huge expense. We were not even sure how telemedicine visits were going to be reimbursed, so we brought that to the attention of Congress. Those visits are now reimbursed, thanks in great part to the Centers for Medicare & Medicaid Services. And now that telemedicine—as well as phone visits for patients without internet access—has proven to be very helpful for our patients, we need to continue working with the newly elected Congress to keep those options available to us and reimbursed.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

TR: Has the pandemic affected how you advocate for rheumatology?

Dr. Ziglar: There’s a camaraderie and a level of comfort that you can have when you meet legislators and their staff in person. That’s harder to attain when communicating through a screen, but with email, online meetings, Twitter, Facebook and any number of other platforms, we are still getting the word out.

TR: Who would you encourage to become an advocate?

Dr. Ziglar: Everyone can be an advocate. You don’t have to start right out of a fellowship. Like me, you can be someone who has been in the clinic for many years, finally have the kids out of their diapers and have extra time to feed your desire to speak up about injustices or problems that you see from day to day. One of the fastest and easiest ways to get started is to click on the links in call-for-action emails from the ACR, type in your personal experience and send it. That helps to really magnify and increase the momentum of the issues that we at the GAC want to push through. I also encourage everyone to support RheumPAC, which will likewise champion our causes.

All advocacy is important. The more we stay silent and hold back our opinions, the less likely we are going to be able to help each other as practitioners and also our patients, who rely on us to be their voice.


Leslie Mertz, PhD, is a freelance science journalist based in northern Michigan.

Every ACR/ARP member can advance rheumatology by being an advocate for rheumatology issues, practices and patients. Find tools and resources from the ACR to guide your advocacy journey.

Filed Under: Legislation & Advocacy, Profiles Tagged With: Advocacy, Government Affairs Committee (GAC), Louisa Ziglar

You Might Also Like:
  • Advocate from Your Office the Week of March 14
  • Everybody Is Doing It: Are You an Advocate?
  • Why I Advocate for Rheumatology: Teaching the Basics
  • Advocate for Rheumatology Issues During Election Season

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.